Regulatory scientific advice on non-inferiority drug trials.

PLoS One · 2013 · PMC3764030 · PMID 24040346

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

[8] A difference of 0.1% of HbA1C may not be significant in the clinic, but this difference will result in two largely different sample size calculations in non-inferiority trials.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.